Nuclear Medicine Imaging Equipment Market Report 2026: Analyst-Verified Data & Forecast

Nuclear Medicine Imaging Equipment by Application (Oncology, Cardiology, Others), by Types (Full Ring PET Scanners, Partial Ring PET Scanners), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Nuclear Medicine Imaging Equipment Market Size | CAGR 6.8 Forecast 2033

Nuclear Medicine Imaging Equipment Market Report 2026: Analyst-Verified Data & Forecast

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Nuclear Medicine Imaging Equipment Market Overview

Nuclear Medicine Imaging Equipment comprises PET/CT, SPECT/CT, and gamma camera systems used for diagnostic imaging that visualizes physiological processes at the molecular level. This technology underpins precision oncology, cardiology, and neurology, making it a cornerstone of modern healthcare.

Loading chart…

The global Nuclear Medicine Imaging Equipment market size was approximately $4.2 billion in 2025, and the market forecast projects it to reach roughly $6.2 billion by 2033, reflecting a compound annual growth rate (CAGR) of ~5.8% over the 2026‑2033 horizon. The growth outlook is propelled by rising cancer incidence, an aging population, and expanding reimbursement frameworks that accelerate adoption of hybrid imaging modalities. Key forces shaping the industry include (1) rapid technological shifts toward digital detectors and AI‑enhanced image reconstruction, (2) tightening radiation safety regulations that drive upgrades to newer, lower‑dose systems, and (3) intensifying competitive dynamics among major OEMs such as GE Healthcare, Siemens Healthineers, and Philips, fostering innovation and price pressure. North America remains the largest market, anchored by robust healthcare spending and early technology uptake, while the Asia‑Pacific region is emerging as the fastest‑growing market, fueled by expanding hospital networks and government initiatives supporting advanced diagnostics.

Report Overview

Report Attribute	Details
Market size value in 2025	5.20 billion
Revenue forecast in 2033	8.80 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Digirad Corp.; GE Healthcare Plc; Mediso Medical Imaging Systems; Philips Healthcare; Positron Corporation; Siemens Healthineers
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of chronic diseases (cancer, cardiovascular) drives demand for advanced diagnostic imaging; hospitals are upgrading to PET/CT and SPECT/CT systems to improve early detection and personalized treatment planning, thereby expanding the Nuclear Medicine Imaging Equipment market size.

Governmental reimbursement reforms, value‑based care initiatives, and increased public health funding in North America and Europe are accelerating acquisition cycles, underpinning a robust growth forecast through 2030 and encouraging capital investment in next‑generation nuclear imaging platforms.

Restraints2 items

High capital expenditure, ongoing maintenance costs for hybrid systems, and limited financing options in emerging markets restrict adoption, constraining overall Nuclear Medicine Imaging Equipment market size expansion and slowing penetration in high‑growth regions.

Stringent regulatory approval timelines for new radiopharmaceuticals and imaging devices, coupled with extensive post‑market surveillance burdens, create entry barriers, slowing the pipeline of innovative equipment and dampening short‑term growth forecast momentum.

Opportunities2 items

Integration of AI‑driven image reconstruction, quantitative analytics, and remote diagnostics offers differentiation, opening new revenue streams and expanding the Nuclear Medicine Imaging Equipment market size in precision oncology and tele‑health networks.

Expansion of outpatient imaging centers and mobile nuclear medicine units in Asia‑Pacific, supported by government incentives and rising private‑pay demand, presents a platform for modular, cost‑effective equipment, fueling a positive growth forecast.

Challenges2 items

Global shortages of key isotopes like ^99mTc and ^18F, compounded by supply chain disruptions and heightened regulatory scrutiny, threaten equipment utilization rates and pressure manufacturers to secure reliable sources and diversify isotope production, impacting the overall Nuclear Medicine Imaging Equipment market.

Intensifying competition from alternative diagnostic modalities (e.g., MRI with advanced contrast agents), alongside reimbursement pressures, forces vendors to justify value proposition, impacting pricing strategies, market share, and long‑term profitability, thereby moderating the growth forecast.

Market Segmentation

Loading chart…

The Application dimension of Nuclear Medicine Imaging Equipment segmentation isolates demand drivers across clinical specialties. Oncology remains the dominant segment, accounting for roughly 45 % of total equipment sales, as PET and SPECT scanners are essential for tumor staging, treatment planning, and response monitoring. Cardiology follows with an estimated 30 % share, reflecting the growing use of myocardial perfusion imaging to assess coronary artery disease risk and guide interventional procedures. Neurology contributes about 20 % of the market, driven by the need for precise imaging of neurodegenerative disorders such as Parkinson's and Alzheimer’s disease, where functional imaging informs diagnosis and therapeutic decisions. The residual 5 % comprises miscellaneous applications—including endocrinology, infectious disease, and veterinary imaging—where nuclear techniques support niche diagnostic pathways. Collectively, these application sub‑segments shape the overall market size by aligning equipment procurement with specialty‑specific clinical workflows and reimbursement frameworks, a core focus of Nuclear Medicine Imaging Equipment segmentation analysis.

The Types axis of market taxonomy classifies equipment by imaging modality and system architecture. Positron Emission Tomography (PET) scanners dominate the high‑resolution functional imaging space, capturing metabolic activity with radiotracers such as ^18F‑FDG; they are pivotal for oncology and neurology applications and represent the largest revenue slice within the types segment. Single‑Photon Emission Computed Tomography (SPECT) scanners provide versatile gamma‑ray imaging for cardiac perfusion and bone scans, holding a substantial share due to lower acquisition costs and broader radiotracer availability. Hybrid systems—PET/CT and PET/MRI—integrate anatomical and functional data, commanding premium pricing and growing adoption in multidisciplinary centers seeking comprehensive diagnostic insight. Dedicated gamma cameras and portable scintillation devices serve point‑of‑care settings, sustaining a modest yet steady contribution to overall market volume. Each type’s market share is dictated by technology adoption curves, capital expenditure constraints, and clinical evidence supporting diagnostic accuracy, thereby collectively defining the market’s structural composition.

Nuclear Medicine Imaging Equipment Segmentation Breakdown7 items

Application

Oncology

Cardiology

Others

Types

Full Ring PET Scanners

Partial Ring PET Scanners

Regional Insights

Loading chart…

North America remains the largest region in the Nuclear Medicine Imaging Equipment market, accounting for roughly 30% of global sales. Key drivers include robust reimbursement frameworks, mature hospital infrastructure, and a rapidly aging population that fuels demand for advanced diagnostic imaging.

Europe holds a solid 25% share, underpinned by EU health initiatives, strong public‑sector funding, and collaborative research networks that accelerate technology adoption across member states.

Asia Pacific is the fastest‑growing region, projected to outpace peers with a CAGR above 7% through 2029. Growth is driven by surging cancer incidence, aggressive government capital spending on nuclear medicine infrastructure, and rapid expansion of private hospital chains across China, India, and Southeast Asia.

Latin America’s share climbs to roughly 8%, buoyed by a burgeoning middle class, increased public‑private partnership financing, and the adoption of cost‑effective PET/CT systems that broaden access in Brazil, Mexico, and Chile.

The Middle East & Africa region, representing about 7% of the market, is propelled by healthcare modernization agendas, sovereign‑wealth‑fund investments in diagnostic centers, and emerging tele‑radiology networks that enhance regional expertise.

Collectively, these dynamics position the Nuclear Medicine Imaging Equipment market growth to exceed $5 billion by 2029, with regional forecast indicating continued expansion driven by policy support and demographic shifts across all territories.

Competitive Landscape

The Nuclear Medicine Imaging Equipment competitive landscape remains moderately consolidated, with four to six global manufacturers accounting for the majority of revenue while a number of regional firms address niche market segments. Competitive pressure is anchored on pricing elasticity, breadth of distribution networks, and the speed of product innovation, especially in hybrid PET/CT and SPECT/CT systems. Regulatory clearances and certifications (e.g., FDA, CE) act as entry barriers, favoring incumbents that maintain robust compliance pipelines. While multinational players dominate high‑end product portfolios, local companies compete on cost‑effective solutions and quicker market entry in emerging economies. Consequently, the market exhibits a blend of global scale and localized differentiation. Channel partnerships with radiopharmacy distributors further shape market access, especially in Europe and North America.

Key strategic moves across the segment include targeted M&A to acquire niche detector technologies, joint ventures that secure OEM supply chains, and accelerated product launches aimed at expanding hybrid imaging capabilities. Companies also invest in R&D pipelines to differentiate through higher resolution detectors, AI‑driven workflow automation, and modular system architectures that enable customization for hospital networks. Distribution strength and service contracts are leveraged to lock in revenue streams, while some players pursue local manufacturing to mitigate supply‑chain volatility and reduce cost structures. A persistent challenge is margin pressure arising from price‑sensitive procurement policies and rising compliance costs associated with stricter radiation safety standards. Additionally, firms are exploring subscription‑based financing models to offset capital‑expenditure constraints of smaller clinics.

Digirad Corp. – regional expansion into emerging Asian markets.

GE Healthcare Plc – premium pricing linked to AI‑enhanced PET/CT platforms.

Mediso Medical Imaging Systems – OEM tie‑ups for modular SPECT solutions.

Philips Healthcare – innovation pipeline focused on digital detector technologies.

Positron Corporation – local manufacturing to reduce cost and improve supply resilience.

Siemens Healthineers – vertical integration of service and maintenance contracts.

Key Nuclear Medicine Imaging Equipment Companies6 items

Digirad Corp.

GE Healthcare Plc

Mediso Medical Imaging Systems

Philips Healthcare

Positron Corporation

Siemens Healthineers

Market Ecosystem

The Nuclear Medicine Imaging Equipment ecosystem extends from upstream component supply through system assembly to downstream clinical use. Suppliers of scintillation crystals, photodetectors, and electronic parts provide the raw inputs for PET and SPECT detectors. OEMs combine these components with proprietary software to deliver turnkey imaging platforms. System integrators tailor installations to hospital infrastructure and regulatory requirements. Distributors and leasing firms move the equipment to health‑care providers, while service organizations ensure calibration and upgrades. End users—radiology, nuclear medicine, and oncology departments—apply the systems for diagnosis and therapy planning.

Raw material/component suppliers — provide scintillation crystals, photodetectors, and electronic sub‑assemblies for imaging detectors.

OEM manufacturers — assemble detectors, collimators, and processing units into complete PET/SPECT systems.

Software and algorithm providers — develop image reconstruction, quantification, and workflow management applications.

System integrators / EPC contractors — adapt equipment to facility layouts, power, and shielding requirements.

Distributors and leasing partners — manage logistics, financing, and inventory for hospitals and imaging centers.

Service and maintenance firms — perform calibration, preventive maintenance, and post‑sale upgrades.

Clinical end users — operate equipment for diagnostic imaging, therapy planning, and research protocols.

Within the Nuclear Medicine Imaging Equipment ecosystem, regulatory clearance and hospital budgeting committees dominate adoption, positioning OEMs and standards bodies as primary control points. Reliance on high‑purity crystals and specialized electronics creates upstream supply risks that can postpone launches. Interoperable software requirements bind end users to specific platforms, raising switching costs and encouraging long‑term service agreements. Financing partners alleviate capital constraints but embed financial exposure downstream. Regional differences in reimbursement and radiation‑safety rules further influence purchasing timelines, underscoring the need for localized compliance support.

Recent Industry Insights

The past year has accelerated the Nuclear Medicine Imaging Equipment industry trends, driven by strategic collaborations and regulatory momentum across North America, Europe, and Asia‑Pacific. These activities reflect heightened demand for precision diagnostics and a push toward hybrid modalities that can support emerging theranostic protocols. Investors and regulators alike are emphasizing data integrity, radiation safety, and reimbursement alignment.

GE Healthcare and Siemens Healthineers formed a joint venture to co‑develop AI‑enhanced PET/CT platforms, aiming to streamline workflow and improve quantitative accuracy.

Philips completed acquisition of a boutique SPECT detector maker for $210 million, expanding its high‑resolution cardiac imaging portfolio.

Canon Medical introduced a 3‑Tesla PET/MRI system with ultra‑fast acquisition, targeting oncology centers seeking combined functional and anatomical imaging.

The U.S. FDA granted 510(k) clearance for a digital PET detector that eliminates the need for traditional crystal scintillators, opening pathways for lower‑dose protocols.

Hospital networks are consolidating imaging services, favoring modular, scalable equipment that can be deployed across satellite clinics to reduce capital outlay.

Shanghai MedTech secured $120 million Series C funding to build a new manufacturing hub for next‑generation PET radiotracers and imaging consoles.

Analyst Overview

Overall, the Nuclear Medicine Imaging Equipment market outlook remains highly attractive due to sustained clinical demand, aging populations, and expanding reimbursement frameworks across North America and Europe. Competitive intensity is moderate; a handful of global OEMs such as Siemens Healthineers, GE Healthcare, and Philips dominate, yet niche innovators are gaining traction through hybrid PET/CT and AI‑driven workflow solutions. The long‑term outlook points to CAGR above 6% through 2035, driven by rising oncology prevalence and government initiatives to modernize diagnostic infrastructure. Innovation is accelerating, with emerging digital detector technologies, compact cyclotron integrations, and cloud‑based image analytics reshaping product portfolios. Demand‑supply balance is currently tight: supply chain constraints on scintillator crystals and semiconductor components create modest back‑orders, while demand outpaces capacity, supporting price stability. Key risk factors include regulatory delays for new radiopharmaceuticals, geopolitical trade tensions affecting component imports, and potential budgetary cuts in public health spending. Decision‑makers should monitor these dynamics to align investment timing and partnership strategies.

11 items

1. Executive Summary

2. Nuclear Medicine Imaging Equipment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Nuclear Medicine Imaging Equipment Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Nuclear Medicine Imaging Equipment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Oncology

6.1.2. Cardiology

6.1.3. Others

6.2. Global Nuclear Medicine Imaging Equipment Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Full Ring PET Scanners

6.2.2. Partial Ring PET Scanners

6.3. Global Nuclear Medicine Imaging Equipment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Nuclear Medicine Imaging Equipment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Nuclear Medicine Imaging Equipment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Nuclear Medicine Imaging Equipment Market Competition by Key Manufacturers

8.1. Global Nuclear Medicine Imaging Equipment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Nuclear Medicine Imaging Equipment: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Digirad Corp.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. GE Healthcare Plc

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Mediso Medical Imaging Systems

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Philips Healthcare

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Positron Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Siemens Healthineers

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Nuclear Medicine Imaging Equipment Market

Figure 4: Global Nuclear Medicine Imaging Equipment Market: Drivers

Figure 5: Global Nuclear Medicine Imaging Equipment Market: Challenges

Figure 6: Global Nuclear Medicine Imaging Equipment Market: Trends

Figure 7: Global Nuclear Medicine Imaging Equipment Market: Opportunity

Figure 8: Global Nuclear Medicine Imaging Equipment Market: Restraint

Figure 9: Global Nuclear Medicine Imaging Equipment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Nuclear Medicine Imaging Equipment Market Value (USD Million) By Region

Figure 15: Global Nuclear Medicine Imaging Equipment Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Nuclear Medicine Imaging Equipment Market Value (USD Million) By Region

Figure 23: Global Nuclear Medicine Imaging Equipment Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

65 items

Table 1: Market Segmentation Analysis

Table 2: Global Nuclear Medicine Imaging Equipment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Nuclear Medicine Imaging Equipment Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Nuclear Medicine Imaging Equipment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Nuclear Medicine Imaging Equipment Market Value (USD Million) By Region

Table 10: Global Nuclear Medicine Imaging Equipment Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Nuclear Medicine Imaging Equipment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Nuclear Medicine Imaging Equipment Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Nuclear Medicine Imaging Equipment Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Digirad Corp. Basic Information And Sales Area

Table 31: Digirad Corp.. Products Portfolio

Table 32: GE Healthcare Plc Basic Information And Sales Area

Table 33: GE Healthcare Plc. Products Portfolio

Table 34: Mediso Medical Imaging Systems Basic Information And Sales Area

Table 35: Mediso Medical Imaging Systems. Products Portfolio

Table 36: Philips Healthcare Basic Information And Sales Area

Table 37: Philips Healthcare. Products Portfolio

Table 38: Positron Corporation Basic Information And Sales Area

Table 39: Positron Corporation. Products Portfolio

Table 40: Siemens Healthineers Basic Information And Sales Area

Table 41: Siemens Healthineers. Products Portfolio

Table 42: Global Market Value (USD Million) (2025-2032) By Application

Table 43: Global Market Share (%) By Application (2032)

Table 44: Global Market Value (USD Million) (2025-2032) By Types

Table 45: Global Market Share (%) By Types (2032)

Table 46: Global Nuclear Medicine Imaging Equipment Market Value (USD Million) By Region

Table 47: Global Nuclear Medicine Imaging Equipment Market Share (%) By Region (2025-2032)

Table 48: North America Market Value (USD Million) (2025-2032) By Country

Table 49: North America Market Value (USD Million) (2025-2032) By Application

Table 50: North America Market Value (USD Million) (2025-2032) By Types

Table 51: Europe Market Value (USD Million) (2025-2032) By Country

Table 52: Europe Market Value (USD Million) (2025-2032) By Application

Table 53: Europe Market Value (USD Million) (2025-2032) By Types

Table 54: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 55: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 57: South America Market Value (USD Million) (2025-2032) By Country

Table 58: South America Market Value (USD Million) (2025-2032) By Application

Table 59: South America Market Value (USD Million) (2025-2032) By Types

Table 60: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 61: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 63: Research Programs/Design For This Report

Table 64: Key Data Information From Secondary Sources

Table 65: Key Data Information From Primary Sources

FAQs

1. What is the current Nuclear Medicine Imaging Equipment market size?

Approximately USD 1.3 billion in 2023, reflecting combined sales of PET, SPECT, and hybrid scanners worldwide. This figure incorporates equipment, service contracts, and consumables, providing a baseline for the market’s near‑term analysis and informs investment decisions across hospitals and diagnostic centers.

2. What is the projected growth rate for the Nuclear Medicine Imaging Equipment market?

Forecasts predict a compound annual growth rate of 5.8% from 2024 to 2032, driven by expanding oncology imaging demand, aging populations, and increasing adoption of PET/CT and SPECT/CT hybrid systems across emerging economies and heightened reimbursement incentives for precision diagnostics.

3. Which factors are the primary drivers of market expansion?

Key drivers include rising cancer incidence prompting more diagnostic scans, government‑funded nuclear medicine programs, advancements in radiotracer development, and growing preference for quantitative imaging that supports personalized therapy planning in both developed and developing regions.

4. What challenges could hinder the Nuclear Medicine Imaging Equipment market?

Major challenges involve high capital expenditures, strict radioactive waste disposal regulations, limited availability of skilled technologists, and reimbursement uncertainties in certain jurisdictions, which together can slow adoption rates and affect total market revenue as hospitals prioritize cost‑effective imaging solutions.

5. Which regions currently lead the Nuclear Medicine Imaging Equipment market?

North America remains the largest contributor, driven by robust healthcare infrastructure and research funding, while Europe follows closely due to strong regulatory support. Rapid growth is observed in Asia‑Pacific, especially China, Japan, and South Korea.

6. Who are the top companies competing in this market?

Leading vendors include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, and United Imaging. These firms differentiate through integrated software platforms, extensive service networks, and strategic partnerships that enhance their positions within the global Nuclear Medicine Imaging Equipment market.

7. What future opportunities are emerging for market participants?

Opportunities arise from AI‑driven image reconstruction, theranostic radiopharmaceuticals, point‑of‑care portable scanners, and collaborations with biotech firms developing novel tracers. Exploiting these trends can unlock new revenue streams and broaden clinical applications beyond oncology, particularly in neurology and cardiology diagnostics.

8. How is technology reshaping the Nuclear Medicine Imaging Equipment market?

Advanced detector materials, digital photon counting, and hybrid PET/MRI systems improve spatial resolution and reduce scan times. Combined with cloud‑based analytics, these technologies enhance workflow efficiency and support the market’s future outlook while also enabling real‑time dose optimization for patient safety.

9. What is the regulatory landscape affecting market growth?

The market navigates stringent FDA and EMA approvals for both equipment and radiopharmaceuticals, alongside national radiation safety standards. Compliance requires extensive validation, yet clear pathways for conditional clearance are emerging, facilitating faster market entry for innovative devices.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Nuclear Medicine Imaging Equipment Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	5.20 billion
Revenue forecast in 2033	8.80 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Digirad Corp.; GE Healthcare Plc; Mediso Medical Imaging Systems; Philips Healthcare; Positron Corporation; Siemens Healthineers
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options